Transforming Antimicrobial Research
NCCR AntiResist is transforming antimicrobial research by targeting in vivo pathogen behaviour.
Antimicrobial resistance (AMR), the evolved ability of bacteria and other microbes to evade antibiotic treatment, is now a global threat to humanity, with the bacteria resistant to one or more antibiotics increasing rapidly. After thirty years of stagnation in the development of new antibiotics, we are faced with the very near prospect of a post-antibiotic era with common infections again becoming life-threatening. We are rising to meet that challenge.
AMR is a global problem. We therefore embrace the principles of open science and collaboration, and are proud to publish our research, so that scientists around the world can see, expand and build on our work.